# Neonc Technologies Holdings, Inc.: filings

NTHI · Nasdaq · CIK 1979414 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nthi.md) · [Financials](/companies/nthi/financials.md) · [Filings](/companies/nthi/filings.md) · [Insiders](/companies/nthi/insiders.md)

## Reports and events: 75 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 52, 4 38, 3 15, 4/A 12, CORRESP 11, UPLOAD 10, 424B5 8, EFFECT 8, D 7, S-1 6, S-1/A 6, 10-Q 5, DRS/A 3, S-3 3, 424B4 2, 8-K/A 2, DRS 2, 10-K 1, 10-K/A 1, 144 1, 3/A 1, 8-A12B 1, CERT 1, DEF 14A 1, DEFA14A 1, FWP 1, NT 10-Q 1, PRE 14A 1, RW 1, S-8 1, SCHEDULE 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 21:20 ET | [8-K](/filings/0001829126-26-011446.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-011446 |
| 2026-10-15 | 20:30 ET | [8-K](/filings/0001829126-26-011189.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-011189 |
| 2026-09-28 | 21:00 ET | [8-K](/filings/0001829126-26-010493.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-010493 |
| 2026-09-21 | 20:30 ET | [8-K](/filings/0001829126-26-010282.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-010282 |
| 2026-09-17 | 10:02 ET | [8-K](/filings/0001829126-26-010156.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-010156 |
| 2026-09-10 | 14:27 ET | [8-K](/filings/0001829126-26-009977.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-009977 |
| 2026-08-21 | 18:58 ET | [8-K/A](/filings/0001829126-26-009220.md) | 5.02 Departure or appointment of officers or directors | 0001829126-26-009220 |
| 2026-08-20 | 13:00 ET | [8-K](/filings/0001829126-26-009103.md) | 5.07 Shareholder vote results | 0001829126-26-009103 |
| 2026-08-13 | 21:21 ET | [8-K](/filings/0001829126-26-008773.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-008773 |
| 2026-08-12 | 12:30 ET | [8-K](/filings/0001829126-26-008654.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-008654 |
| 2026-08-10 | 21:15 ET | [8-K](/filings/0001829126-26-008543.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-008543 |
| 2026-08-10 | 13:00 ET | [10-Q](/filings/0001829126-26-008512.md) | Quarterly report, period 2026-06-30 | 0001829126-26-008512 |
| 2026-07-15 | 13:15 ET | [8-K](/filings/0001829126-26-007585.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-007585 |
| 2026-07-02 | 21:11 ET | [8-K](/filings/0001829126-26-007213.md) | 5.02 Departure or appointment of officers or directors | 0001829126-26-007213 |
| 2026-06-23 | 21:08 ET | [DEF 14A](/filings/0001829126-26-006775.md) | Proxy statement, period 2026-08-14 | 0001829126-26-006775 |
| 2026-06-23 | 21:00 ET | [8-K](/filings/0001829126-26-006773.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-006773 |
| 2026-06-18 | 21:00 ET | [8-K](/filings/0001829126-26-006688.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-006688 |
| 2026-06-12 | 10:01 ET | [8-K](/filings/0001829126-26-006400.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001829126-26-006400 |
| 2026-05-18 | 21:00 ET | [8-K](/filings/0001829126-26-005421.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-005421 |
| 2026-05-15 | 20:32 ET | [10-Q](/filings/0001829126-26-005358.md) | Quarterly report, period 2026-03-31 | 0001829126-26-005358 |
| 2026-05-05 | 01:41 ET | [10-K/A](/filings/0001829126-26-004495.md) | Annual report, amended, period 2025-12-31 | 0001829126-26-004495 |
| 2026-04-24 | 21:00 ET | [8-K](/filings/0001829126-26-003882.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001829126-26-003882 |
| 2026-04-16 | 21:00 ET | [8-K](/filings/0001829126-26-003566.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-003566 |
| 2026-04-10 | 20:31 ET | [8-K](/filings/0001829126-26-003401.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001829126-26-003401 |
| 2026-04-03 | 21:00 ET | [8-K](/filings/0001829126-26-003165.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-003165 |
| 2026-03-31 | 10:05 ET | [10-K](/filings/0001829126-26-002860.md) | Annual report, period 2025-12-31 | 0001829126-26-002860 |
| 2026-03-23 | 21:00 ET | [8-K](/filings/0001829126-26-002610.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001829126-26-002610 |
| 2026-03-17 | 22:24 ET | [8-K](/filings/0001829126-26-002331.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-002331 |
| 2026-03-06 | 22:01 ET | [8-K](/filings/0001829126-26-002020.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-002020 |
| 2026-03-04 | 22:00 ET | [8-K](/filings/0001829126-26-001927.md) | 8.01 Other events | 0001829126-26-001927 |
| 2026-03-03 | 22:00 ET | [8-K](/filings/0001829126-26-001885.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001829126-26-001885 |
| 2026-02-27 | 22:01 ET | [8-K](/filings/0001829126-26-001755.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-001755 |
| 2026-02-06 | 21:48 ET | [S-1](/filings/0001829126-26-001064.md) | Registration statement | 0001829126-26-001064 |
| 2026-01-29 | 20:04 ET | [8-K](/filings/0001829126-26-000757.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001829126-26-000757 |
| 2025-12-17 | 21:05 ET | [8-K](/filings/0001829126-25-010101.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-25-010101 |
| 2025-12-15 | 01:36 ET | [S-1](/filings/0001829126-25-009965.md) | Registration statement | 0001829126-25-009965 |
| 2025-12-05 | 22:00 ET | [8-K](/filings/0001829126-25-009754.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-25-009754 |
| 2025-11-14 | 21:46 ET | [8-K](/filings/0001829126-25-009221.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-25-009221 |
| 2025-11-14 | 21:01 ET | [10-Q](/filings/0001829126-25-009210.md) | Quarterly report, period 2025-09-30 | 0001829126-25-009210 |
| 2025-11-12 | 22:06 ET | [8-K](/filings/0001829126-25-009076.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-25-009076 |
| 2025-11-10 | 22:01 ET | [8-K](/filings/0001829126-25-008959.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-25-008959 |
| 2025-11-06 | 22:00 ET | [8-K](/filings/0001829126-25-008902.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-25-008902 |
| 2025-10-30 | 21:00 ET | [8-K](/filings/0001829126-25-008611.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-25-008611 |
| 2025-10-10 | 21:00 ET | [8-K](/filings/0001829126-25-008052.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-25-008052 |
| 2025-10-09 | 13:16 ET | [8-K](/filings/0001829126-25-007973.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-25-007973 |
| 2025-09-11 | 21:00 ET | [8-K](/filings/0001829126-25-007323.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-25-007323 |
| 2025-08-22 | 21:00 ET | [8-K](/filings/0001829126-25-006673.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-25-006673 |
| 2025-08-20 | 23:50 ET | [8-K/A](/filings/0001829126-25-006524.md) | 4.02 Non-reliance on financial statements | 0001829126-25-006524 |
| 2025-08-18 | 16:57 ET | [10-Q](/filings/0001829126-25-006431.md) | Quarterly report, period 2025-06-30 | 0001829126-25-006431 |
| 2025-08-18 | 16:20 ET | [8-K](/filings/0001829126-25-006425.md) | 4.02 Non-reliance on financial statements | 0001829126-25-006425 |

Page 1 of 2. [Older](/companies/nthi/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.